Yakir Levin, MD, PHD
NPI 1376779819 · Dermatology Physician · Boston, MA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1376779819
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD, PHD
- Sex
- Male
- Sole proprietor
- No
- License
- 267029 (MA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
17 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
1,062 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 358 | $8 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 181 | $99 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 144 | $139 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 140 | $58 |
| Biopsy of Related Skin Growth, First Growth11102 | 74 | $102 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 94 | 43 |
| Triamcinolone Acetonide | 48 | 33 |
| Fluorouracil | 45 | 35 |
| Hydrocortisone | 34 | 18 |
| Clobetasol Propionate | 32 | 23 |
| Betamethasone Dipropionate | 23 | 13 |
| Mupirocin | 20 | 18 |
| Doxycycline Monohydrate | 19 | — |
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-06-10
- Last updated
- 2019-02-04
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.